Skip to Content

HeartBeam Inc BEAT

Morningstar Rating
$2.20 +0.02 (0.92%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BEAT is trading within a range we consider fairly valued.
Price
$2.23
Fair Value
$3.53
Uncertainty
Extreme
1-Star Price
$15.15
5-Star Price
$2.98
Economic Moat
Zvsnr
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BEAT is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$2.18
Day Range
$2.202.23
52-Week Range
$1.083.67
Bid/Ask
$0.00 / $0.00
Market Cap
$57.92 Mil
Volume/Avg
30,904 / 198,453

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company’s ability to develop higher-resolution ECG solutions is achieved through the development of the Company’s proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
Sector
Healthcare
Industry
Health Information Services
Stock Style Box
Total Number of Employees
15

Comparables

Valuation

Metric
BEAT
LFST
OPCH
Price/Earnings (Normalized)
31.21
Price/Book Value
3.671.604.07
Price/Sales
2.101.39
Price/Cash Flow
131.3715.24
Price/Earnings
BEAT
LFST
OPCH

Financial Strength

Metric
BEAT
LFST
OPCH
Quick Ratio
13.561.011.17
Current Ratio
14.091.111.77
Interest Coverage
−8.748.00
Quick Ratio
BEAT
LFST
OPCH

Profitability

Metric
BEAT
LFST
OPCH
Return on Assets (Normalized)
−89.43%−4.64%9.04%
Return on Equity (Normalized)
−100.02%−6.76%20.48%
Return on Invested Capital (Normalized)
−105.93%−4.11%12.73%
Return on Assets
BEAT
LFST
OPCH
See how this stock stacks up to its competitors with Morningstar Investor

Health Information Services Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
GEHC
GE HealthCare Technologies Inc Common StockFdmblbc$41.1 Bil
VEEV
Veeva Systems Inc Class ACmkghkmzzwXgc$37.6 Bil
MTHRF
M3 IncZzkbd$9.6 Bil
MTHRY
M3 Inc ADRFldds$9.6 Bil
PMCUF
Pro Medicus LtdLrsmlgv$7.0 Bil
HQY
HealthEquity IncYcdwp$6.9 Bil
RCM
R1 RCM IncHksb$5.5 Bil
DOCS
Doximity Inc Class AFjzhnb$5.0 Bil
TXG
10x Genomics Inc Ordinary Shares - Class AStz$4.4 Bil
EVH
Evolent Health Inc Class ADptw$3.7 Bil

Sponsor Center